激活暗基因组以照亮癌症疫苗靶点。
Activating the dark genome to illuminate cancer vaccine targets.
机构信息
Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA.
Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
出版信息
Nat Genet. 2024 Sep;56(9):1770-1771. doi: 10.1038/s41588-024-01850-3.
Abstract
Epigenetic therapy awakens myriad transposable elements to generate new antigens that could prime tumor cells for immunotherapy. A new study of glioblastoma discovers indiscriminate awakening in normal cells also and then presents a more selective strategy for potential therapeutic targeting.
摘要
表观遗传疗法唤醒了无数转座元件，产生新的抗原，从而使肿瘤细胞能够对免疫疗法产生反应。一项新的胶质母细胞瘤研究发现，正常细胞也会被不加区分地唤醒，然后提出了一种更具选择性的潜在治疗靶点策略。
相似文献
1
Activating the dark genome to illuminate cancer vaccine targets.激活暗基因组以照亮癌症疫苗靶点。
Nat Genet. 2024 Sep;56(9):1770-1771. doi: 10.1038/s41588-024-01850-3.
2
Listeria vaccines join the checkpoint frenzy.李斯特菌疫苗也加入了免疫检查点热潮。
Nat Biotechnol. 2014 Dec;32(12):1176-7. doi: 10.1038/nbt1214-1176d.
3
CRISPR cures and cancer vaccines: researchers can help to shepherd them to market.CRISPR疗法与癌症疫苗：研究人员可助力将它们推向市场。
Nature. 2024 Jun;630(8016):269. doi: 10.1038/d41586-024-01714-0.
4
Applications of Next-Generation Sequencing in Neoantigen Prediction and Cancer Vaccine Development.下一代测序在新抗原预测和癌症疫苗开发中的应用。
Genet Test Mol Biomarkers. 2020 Feb;24(2):59-66. doi: 10.1089/gtmb.2018.0211. Epub 2019 Mar 22.
5
T cell response to tumor antigens and its therapeutic use in cancer patients.T细胞对肿瘤抗原的反应及其在癌症患者中的治疗应用。
Adv Exp Med Biol. 2001;495:403-10. doi: 10.1007/978-1-4615-0685-0_59.
6
Therapeutic mRNA vaccine applications in oncology.治疗性mRNA疫苗在肿瘤学中的应用。
Mol Ther. 2025 Jun 4;33(6):2610-2618. doi: 10.1016/j.ymthe.2025.04.044. Epub 2025 May 6.
7
The next generation of vaccines for the treatment of cancer.用于治疗癌症的下一代疫苗。
Curr Opin Mol Ther. 1999 Feb;1(1):57-63.
8
Cancer vaccine and immunotherapy.癌症疫苗与免疫疗法。
Curr Pharm Des. 2005;11(27):3459-60. doi: 10.2174/138161205774414592.
9
Rekindling cancer vaccines.重启癌症疫苗
Nat Biotechnol. 2016 Oct 11;34(10):1019-1024. doi: 10.1038/nbt.3690.
10
Neoantigen Cancer Vaccines: Real Opportunity or Another Illusion?新型抗原癌症疫苗：真正的机遇还是另一个幻象？
Arch Immunol Ther Exp (Warsz). 2021 Apr 28;69(1):12. doi: 10.1007/s00005-021-00615-8.
引用本文的文献
1
Harnessing immunotherapy: cancer vaccines as novel therapeutic strategies for brain tumor.利用免疫疗法：癌症疫苗作为脑肿瘤的新型治疗策略
Front Immunol. 2025 Jul 17;16:1588081. doi: 10.3389/fimmu.2025.1588081. eCollection 2025.
2
Functional Characterization of LTR12C as Regulators of Germ-Cell-Associated TA-p63 in U87-MG and T98-G In Vitro Models.LTR12C作为U87-MG和T98-G体外模型中生殖细胞相关TA-p63调节因子的功能表征
Cells. 2025 Jun 5;14(11):852. doi: 10.3390/cells14110852.
3
Unlocking the secrets of the immunopeptidome: MHC molecules, ncRNA peptides, and vesicles in immune response.揭开免疫肽组的秘密：主要组织相容性复合体分子、非编码RNA肽与免疫应答中的囊泡
Front Immunol. 2025 Jan 29;16:1540431. doi: 10.3389/fimmu.2025.1540431. eCollection 2025.
本文引用的文献
1
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective.从三维全肿瘤角度看胶质母细胞瘤的演变和异质性。
Cell. 2024 Jan 18;187(2):446-463.e16. doi: 10.1016/j.cell.2023.12.013.
2
Pan-cancer analysis identifies tumor-specific antigens derived from transposable elements.泛癌分析鉴定出来自转座元件的肿瘤特异性抗原。
Nat Genet. 2023 Apr;55(4):631-639. doi: 10.1038/s41588-023-01349-3. Epub 2023 Mar 27.
3
Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer.外显子和转座元件之间的非规范剪接接头是肺癌患者免疫原性复发新抗原的来源。
Sci Immunol. 2023 Feb 3;8(80):eabm6359. doi: 10.1126/sciimmunol.abm6359.
4
Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides.基于单细胞 RNA 测序的蛋白质基因组学鉴定出编码 HLA-I 呈递肽的神经胶质瘤特异性转座元件。
Cell Rep. 2022 Jun 7;39(10):110916. doi: 10.1016/j.celrep.2022.110916.
5
Glioblastoma: clinical presentation, diagnosis, and management.胶质母细胞瘤：临床表现、诊断与治疗
BMJ. 2021 Jul 14;374:n1560. doi: 10.1136/bmj.n1560.
6
Epigenetic therapy in immune-oncology.免疫肿瘤学中的表观遗传学治疗。
Nat Rev Cancer. 2019 Mar;19(3):151-161. doi: 10.1038/s41568-019-0109-9.
7
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma.内源性逆转录病毒特征可预测透明细胞肾细胞癌的免疫治疗反应。
J Clin Invest. 2018 Nov 1;128(11):4804-4820. doi: 10.1172/JCI121476. Epub 2018 Oct 2.
8
DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats.DNA甲基转移酶（DNMT）和组蛋白去乙酰化酶（HDAC）抑制剂可诱导长末端重复序列中编码的隐蔽转录起始位点。
Nat Genet. 2017 Jul;49(7):1052-1060. doi: 10.1038/ng.3889. Epub 2017 Jun 12.
9
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.抑制DNA甲基化会通过包括内源性逆转录病毒在内的双链RNA在癌症中引发干扰素反应。
Cell. 2015 Aug 27;162(5):974-86. doi: 10.1016/j.cell.2015.07.011.
10
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts.DNA去甲基化剂通过诱导内源性转录本产生病毒模拟来靶向结肠直肠癌细胞。
Cell. 2015 Aug 27;162(5):961-73. doi: 10.1016/j.cell.2015.07.056.
Zotero 插件